Authors of a new study found that estradiol levels can be used to predict fracture risk among women during the menopausal transition.
Expert Insights: Q&A with Mark Ebell, MD, on Gepotidacin and UTI Management
Family physician and researcher Mark Ebell, MD, discusses the clinical implications, efficacy, and role of gepotidacin in UTI management.
New Study Suggests Bacterial Vaginosis May be Sexually Transmitted
New research shows that treating both men and women with topical and oral antibiotics lowers the odds of bacterial vaginosis recurrence by more than half.
Women's Heart Health: 5 Studies from ACC.25
The risks to women's CV health differ, often significantly, from those faced by men, as demonstrated by 5 abstracts from the American College of Cardiology 2025 annual meeting.
FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs
Gepotidacin is the first new oral antibiotic for uncomplicated urinary tract infections in 30 years, offering an alternative amid rising antibiotic resistance.
Maternal Mortality Due to Cardiovascular Disease More Than Doubles in the US
ACC 2025: Black women and women in Southern states faced significantly higher rates of maternal mortality, according to a new study.
More Evidence that Women Face Greater CVD Risk than Men, Even When Baseline Health is Equal
For the same level of baseline health, the increase in risk related to each of 8 key CV risk factors appears significantly higher in women than in men.